Singapore Institute of Advanced Medicine Holdings Ltd. (SG:9G2) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The Singapore Institute of Advanced Medicine Holdings Ltd. has announced that its subsidiary, Proton Therapy Pte. Ltd., has entered into a three-year agreement with Icon SOC Pte. Ltd. to provide proton therapy treatment services to cancer patients, commencing on 1 July 2024. This partnership signifies a collaborative effort to enhance oncology services by integrating advanced proton therapy into Icon’s comprehensive cancer treatment offerings. The financial terms of the agreement involve a fee schedule for services rendered, with provisions for renewal and termination.
For further insights into SG:9G2 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money